It was determined that positivity for Bcl-2 and CD10 markers had 88% accuracy and 100% specificity in detecting BCC, while CEA and EMA positivity detected SCC with 67% accuracy and 100% specificity [11]. This evidence concerns the gene CEACAM5 and skin basal cell carcinoma.